Orbis Biosciences | 917 followers on LinkedIn | We develop novel controlled-release delivery systems for the pharmaceutical industry. | Orbis Biosciences, Inc. provides controlled-release delivery technologies to create revolutionary pharmaceutical products that are safer and more effective than existing treatment options. For example, Orbis’ Precision Particle Fabrication technology leverages particle engineering to enhance drug release profiles, improve taste-masking, and, ultimately, improve patient outcomes while reducing the total cost of care. Working in collaboration with pharmaceutical and biotech companies, Orbis is integrating its technologies into the next generation of cutting-edge therapies.
View Top Employees from Orbis Biosciences| Website | http://www.orbisbio.com |
| Revenue | $1 million |
| Funding | $1 million |
| Employees | 11 (0 on RocketReach) |
| Founded | 2008 |
| Address | 8006 Reeder St, Lenexa, Kansas 66214, US |
| Phone | (913) 544-1199 |
| Technologies | |
| Industry | Biotechnology, Pharmaceuticals, Controlled-Release, Science and Engineering, Microencapsulation, Healthcare, Health Care, Drug Delivery, Medical, Monodisperse Microspheres |
| Web Rank | 8 Million |
| Keywords | Parenteral Medications, Orbis Biosciences, Advantages Of Parenteral Administration, Controlled Release, Developing Countries With Limited Access To Healthcare |
| Competitors | AMW GmbH, Carticept Medical, Inc., Nemaura Pharma Limited, Oramed Pharmaceuticals Inc., Piedmont Pharmaceuticals |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Orbis Biosciences employee's phone or email?
Orbis Biosciences Questions
The Orbis Biosciences annual revenue was $1 million in 2023.
Orbis Biosciences is based in Lenexa, Kansas.
The NAICS codes for Orbis Biosciences are [32541, 325, 32, 3254].
The SIC codes for Orbis Biosciences are [28, 283].
Related Companies
